Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Not applicableStudy completedNCT01932489What this trial is testingThe Jules Bordet Institute Molecular Profiling Program Feasibility TrialWho this might be right forColorectal Cancer MetastaticMetastatic MelanomaMetastatic Non-Small Cell Lung Carcinoma Jules Bordet Institute 35
Early research (Phase 1)Active Not RecruitingNCT03170960What this trial is testingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forUrothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more Exelixis 914
Testing effectiveness (Phase 2)Study completedNCT04902872What this trial is testingStudy of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsWho this might be right forSolid Tumor, AdultEpithelial Ovarian CancerSmall Cell Lung Carcinoma+9 more Cybrexa Therapeutics 69
Testing effectiveness (Phase 2)Study completedNCT01253837What this trial is testingL19TNFα in Patients With Advanced Solid TumorsWho this might be right forSolid TumorsColorectal Cancer Philogen S.p.A. 34
Not applicableLooking for participantsNCT04673955What this trial is testingBRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC TreatmentWho this might be right forMetastatic Colorectal Carcinoma Pierre Fabre Pharma GmbH 500
Testing effectiveness (Phase 2)Looking for participantsNCT06047379What this trial is testingSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisWho this might be right forDiffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more Neonc Technologies, Inc. 134
Not applicableStudy completedNCT04926376What this trial is testingSafety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)Who this might be right forHepatocellular Carcinoma Non-resectableMetastatic Colorectal CancerLiver Cancer ABK Biomedical 8
Early research (Phase 1)Looking for participantsNCT07630961What this trial is testingPhase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid TumorsWho this might be right forMetastatic Pancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)HR+/HER2- Ductal Breast Cancer (BC)+4 more Novartis Pharmaceuticals 66
Not applicableStudy completedNCT02831842What this trial is testingA Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS StatusWho this might be right forColorectal Cancer Hoffmann-La Roche 4,278
Early research (Phase 1)Study completedNCT02857270What this trial is testingLY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic CancerWho this might be right forAdvanced CancerMetastatic MelanomaMetastatic Non-small Cell Lung Cancer+1 more Eli Lilly and Company 210
Testing effectiveness (Phase 2)Looking for participantsNCT06634875What this trial is testingIsunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)Who this might be right forColorectal Cancer Metastatic Buzzard Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT02063529What this trial is testingFOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Sun Yat-sen University 101
Not applicableStudy completedNCT02378337What this trial is testingDefining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image QualityWho this might be right forMalignant Neoplasm of BreastHodgkin DiseaseNon-Hodgkin Lymphoma, Follicular (Nodular)+5 more Hospital Sao Rafael 335
Early research (Phase 1)Active Not RecruitingNCT05557045What this trial is testingJZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815Who this might be right forAdvanced CancerMetastatic CancerSolid Tumor+4 more Jazz Pharmaceuticals 98
Not applicableActive Not RecruitingNCT04314401What this trial is testingNational Cancer Institute "Cancer Moonshot Biobank"Who this might be right forAcute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more National Cancer Institute (NCI) 1,600
Testing effectiveness (Phase 2)Looking for participantsNCT05870800What this trial is testingPhase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICERWho this might be right forStage I Colon CancerStage II Colon CancerStage III Colon Cancer Baylor College of Medicine 28
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Study completedNCT00942266What this trial is testingVorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous TreatmentWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more Roswell Park Cancer Institute 58